Connect with us

General News

Florida House to Fight Again for Intervening in Medical Marijuana Amendment

Published

on

florida-medical-marijuana

There are still concerns about Florida appropriately acting on the constitutional amendment of 2016 about marijuana legalization. House officials of Florida are once again getting active about it.

The lawyers for the House gave an issue last week that they would be appealing the circuit judge’s ruling that restricted the House to intervene in the 2017 law. It was designed to do the amendment. This came into action as the officials are also looking forward to requesting the first District Court of Appeal to permit the House for intervention in a case regarding the law of 2017.

The circuit judge had made his decision last month

The notice which the officials filed on Friday does not have details regarding the arguments made in the House. However, it is looking forward to inversing a decision that Leon County Circuit Judge Charles Dodson made in May. It did not let the House intervene in Patients and Producers Alliance Inc. lawsuits against the Florida Department of Health.

The Alliance stated that the law of 2017 does not follow the amendment of the constitution as it does not properly limit medical cannabis firms. The House opposed and put forward its demand in the circuit court that it has the right to defend the 2017 law. It can point and address Florida’s need to investigate federal laws that are keeping marijuana illegal.

The House demanded the right to defend the law

The House stated in the circuit court in January that the Representatives make half of Florida’s policy developing body. That is why the house is highly eligible to respond and defend the 2017 law efficiently. The House also pointed out that the amendment of medical marijuana offers authority for just implementation and not for policy development.

The authority for implementation is given to the Department of Health. However, the state constitution power distribution impedes in giving authority for developing policy. The legislative body is the only body having jurisdiction on the constitutional level to develop strategies regarding the implementation of the amendment. These policies will be other than the overriding federal drug policy.

However, the circuit judge delivered an order in May that rejected the House arguments. He cited a decision from November for another case that did not let the House intervene in the matter. Florigrown, a Tampa based firm, has filed a ruling that the House has appealed.

The court did not favor the House

The court held in favor of the Department of Health and stated that the House did not have a direct link and coherence to the issue. The legal operation would not have any direct influence on the House.
The 2017 law attracts a lot of controversies as it places many restrictions on the otherwise unstoppable and booming industry. For instance, it has restricted smoking medical cannabis and in return, drew a big challenge. Governor Ron DeSantis has made efforts since the House lost in the court to lift the ban from smoking medical marijuana.

The House is ready for another hearing on June 11 at the Court of Appeal

The Alliance and lawsuits from Florigrown challenge issues like limitations on firms approvable for doing business and vertical integration. The requirement pushes the firms to expand and sell marijuana for medical purposes. This is an opposition to companies that are given licenses for doing other things in the industry.
The county judge made a decision favoring Florigrown last year. He issued a temporary order that required the health officials of the state to register the firm along with others to continue the business. However, Florida has appealed the injunction, and it will be up for hearing which is due June 11 at the Court of Appeal.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

General News

Global Alliance for Cannabis Commerce announces GACC Certified™ testing

Published

on

The Global Alliance for Cannabis Commerce (GACC) provides policymakers and legislators with the guidance necessary to take the nascent cannabis industry from the gray market into a global provider of medical and adult-use cannabis products.

Recently, the Company announced the launch of a nationwide, voluntary industry certification standard for safety and purity in cannabis product testing. The aim of this program is to provide licensed sellers and consumer confidence that the legal products are safe and they meet the purity standards. By the end of 2020, this program will be available to all state-licensed cannabis operations.

The Executive Director at GACC, Randal John Meyer says that with the current laws it is impossible to make sure that there are uniform standards for purity. Furthermore, GACC President Rezwan Khan added, ”GACC wants to establish a means by which consumers can have confidence in the products they buy and to provide the industry the tools to give this assurance.”

GACC and the member of the companies believe in establishing standards for safety and purity, and in creating a serious and effective testing program. Nominations for membership on the Standards Committee (terms are two years) will be open to the public beginning on Thursday, December 5, 2019, and closing on January 30, 2020.

The Board of GACC will determine the initial composition. Future members will include public nominations and will be determined by the GACCAST Standards Committee and reviewed by the GACC Board of Directors. It is expected that the GACCAST Standards Committee will take approximately nine months to establish the initial standards and protocols so that implementation can begin in 2020.

Brands such as Raw Garden, DNA Genetics, Crockett Family Farms, Urbn Leaf, La Familia, and Team Elite Genetics, and all derivative cannabis products from DNA Genetics’ and Crockett Family Farms’ genetic have pledged to support the development of the standards setting protocol and to adopt and implement it as well when it is effective.

To accommodate the entire legal cannabis industry’s access to this program, GACC will be creating a membership class, the Standard Membership, which involves minimal costs for participation, and that will provide access to the GACC Certified™ Program. GACC is also planning to arrange for testing discounts for members who use the GACC network of laboratories. The GACC President Rezwan Khan added, “Our goal is to ensure this program isn’t cost-prohibitive for any cannabis companies of any size.”

Solo sciences will be offering GACC members a substantial discount on anti-counterfeiting, instant product recall solo*CODE™ technology as they have previously partnered with GACC to ensure that medical patients and adult consumers do not unwittingly purchase counterfeit or illicit vape products.

On this account, the Executive Director of GACC added, “The combination of the voluntary GACC Certified™ consumer safety standard, particularly when combined with members’ access to substantially discounted solo*CODE™ anticounterfeiting technology, allows GACC members to provide their consumers with the confidence they need that anywhere in the United States they legally purchase a participating cannabis product, our blue leaf means it’s safe and genuine.”

Continue Reading

General News

Pasha Brand’s Board Restructuring, announces resignations

Published

on

Pasha Brands Ltd. is one of North America’s largest network and aggregator of craft cannabis. Recently, the Company announced the following resignations: Scott WaltersRosy Mondin and Hugo Alves as directors of the Company. Pasha Brand thanked them for their contributions, time, and efforts.

The Executive Chairman, Patrick Brauckmann stated, ”I’m grateful Scott, Rosy and Hugo shared my vision and were able to contribute to our unique offering. Their resignations will not diminish our resolve to see this project completed, as thousands of cannabis professionals wait in line to re-enter the industry they created.”
However, the resignations are effective immediately.

The Company is now working on establishing a new working board. The idea behind a new board is to solely include people who invested in the brand and its future. The Company’s vision includes giving opportunities for small farmers, legacy brands, the brands excluded by the government, and the founders of Canada’s original cannabis industry. This will help the companies to enter the business world through Pasha’s craft aggregation platform.

Pasha Brand as a Company has proven its capabilities in cannabis cultivation, genetic research and development, product processing, and retail. This makes the Company uniquely positioned in the new legal cannabis market through its network of hundreds of craft cannabis suppliers. Given the opportunity, the brand also plans on refreshing the ranks and reposition the key personnel to reflect the Company’s goal of having Grizzlers™ and Roll Model™ pre-rolls in the market in early 2020.

The Company has many accomplishments under its brand name. Pasha Brand has acquired 8 pre-legalization brands. It established BC Craft Supply Co, which is a solution provider to the micro cultivation community is Canada. It acquired Medcann Health Products Ltd. The Medcann Health Company is a  Health Canada licensed cultivator and processor operating out of a 10,000 square foot facility on Vancouver Island. Another one of the acquired brands is Royal Green Acres Ltd., which is a late stage licensed producer applicant under the ACMPR. The Company established a proprietory platform bringing quality assurance to the craft industry by the name of Craft Labs™.

The Pasha Brand’s common shares trade on the CSE under the symbol “CRFT” and on the FSE under the symbol “ZZD”. Commenting on these changed, the Executive Chairman, Patrick Brauckmann mentioned that he wants a Company that works on the principle of quality and meaning. The Company recruited a strong group of cannabis professionals, brokers and operators, many of who played a part in creating Canada’s original cannabis industry to continue living up to its standards.

Continue Reading

Cannabis

HempMeds® announces partnership with Sezzle, Offers New Payment Solution

Published

on

Medical Marijuana, Inc, the first company to receive historic import permits for CBD products from the governments of BrazilMexicoArgentina, and Paraguay has recently announced a partnership of its subsidiary HempMeds with Sezzel, a leading alternative digital payment platform.

Located in U.S, the first ever publicly traded cannabis company Medical Marijuana inc. has also recently launched a new line of cannabis-derived nutraceutical products, brands and supply chain. As its subsidiary, HempMeds is a corporate portfolio company which is also the Company’s master distributor and contracted marketing company, handling sales and distribution.

Sezzle, a leading alternative digital payment platform offers customers cutting-edge payment alternatives. HempMeds® customers can choose Sezzle at checkout to delay full payment for their items, at zero percent interest. Consumers receive their items right away and Sezzle pays merchant upfront and assumes all repayment risk. It requires a 25 percent down payment at the time of purchase and the remaining balance is automatically scheduled as three equal-installment payments to be paid every two weeks.

President Todd Morrow of HempMeds said that their aim is to provide better services so everyone with a tight budget can afford the benefits. Sezzle offers a “buy-now, pay-later” service that does not require shoppers to enter into a traditional loan or pay any upfront fees or interest. Sezzle is certified up to PCI DSS Level 1 as a Service Provider. He further stated, “Partnering with Sezzle means that we can provide our customers with an easy way to lift some of the financial burden during this expensive time of year.”

HempMeds® was the first company to ever bring hemp-based cannabidiol (CBD) oil products to market in the U.S. and was also the first to make CBD products available in bulk for U.S. consumers. It was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations, as well as the first to have its CBD products listed in the Prescribers’ Digital Reference and one of the first to be certified by the U.S. Hemp Authority.

Medical Marijuana, Inc. CEO Dr. Stuart Titus mentioned, “With the number of new consumers becoming interested in purchasing CBD, we believe that Sezzle is a great opportunity to make our CBD products more accessible to people of all socioeconomic backgrounds.” The number of people searching for e-commerce outlets to purchase CBD has increased every year since 2017. Researchers found that online search volume for CBD in the U.S. increased 160.4 percent in 2018 compared with 2017 and is expected to increase by 117.7 percent in 2019 compared to 2018.

Continue Reading

Trending